Asia Pacific Anti-Rheumatic Market Forecast 2020-2028

Publisher Name :
Date: 03-Apr-2020
No. of pages: 111

KEY FINDINGS

The Asia Pacific anti-rheumatics market is estimated to record a CAGR of 2.38% during the forecast period of 2020-2028. A surge in healthcare expenditure, and the rise in awareness related to the use of anti-rheumatics, are boosting the growth of the market in the region.

MARKET INSIGHTS

The Asia Pacific anti-rheumatics market is further surveyed on the basis of the markets situated in countries such as Indonesia, Japan, China, India, Australia & New Zealand, Vietnam, Thailand, and the rest of Asia Pacific. In South Korea, the prevalence of RA increased annually from 0.28% in 2009 to 0.32% in 2012, according to the NCBI data. The surging prevalence of RA is driving market growth. In countries like Thailand, the market is anticipated to grow at a moderate rate. The prevalence of the medical condition is less as compared to other countries.

In Indonesia, the IRA was established in 1972 in Solo, Central Java, due to the increasing number of rheumatic patients. In August 1982, IRA introduced the first rheumatology course in Indonesia, and has been a pioneer for the development of rheumatology theory, education, research, and practice in Indonesia. DMARDs therapy is expected to modify the continuation of the disease. In Latin America, the market is in its emerging stage, owing to low buying power, inadequate health expenditure, lack of advanced healthcare facilities, and insufficient health coverage in the region. In Brazil, the healthcare system constitutes a large public component, a small paid health insurance, and the patients pay personally for medical services, which hinder the market growth. In Argentine, the prevalence of the disease in the QOM community is among the highest in the world. An increase in the burden of RA in the region is leading to a rise in demand for quicker healthcare services, thereby propelling the market growth.

COMPETITIVE INSIGHTS

Abbott Laboratories, Eli Lilly and Company, Bio-Rad Laboratories Inc, Becton, Dickinson, and Company, Lupin Ltd, etc. are some of the well-established companies operating in the region.

Our report offerings include:

- Explore key findings of the overall market

- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

- Market Segmentation cater to a thorough assessment of key segments with their market estimations

- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Asia Pacific Anti-Rheumatic Market Forecast 2020-2028

Table of Contents

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Rising Geriatric Population
3.2.2. Increasing Opportunities In The Developing Economies
3.2.3. Surge In The Prevalence Of Rheumatoid Arthritis Disease
3.2.4. Growing Healthcare Expenditure
3.3. Key Restraints
3.3.1. Patent Expirations
3.3.2. Lack Of Regulatory Guidelines For Biosimilars Will Delay Their Availability In Some Regions
3.3.3. Less Expensive Alternatives
4. Key Analytics
4.1. Porter's Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer's Power
4.1.4. Supplier's Power
4.1.5. Competitive Rivalry
4.2. Etiology Of Rheumatoid Arthritis (Ra)
4.3. Symptoms Of Rheumatoid Arthritis
4.4. Risk Factors Associated With Rheumatoid Arthritis
4.5. Opportunity Matrix
4.6. Vendor Landscape
4.7. Key Investment Insights
5. Market By Type
5.1. Prescription-Based Drugs
5.2. Over-The-Counter Drugs
6. Market By Drug Class
6.1. Disease Modifying Anti-Rheumatic Drugs
6.2. Nonsteroidal Anti-Inflammatory Drugs
6.3. Corticosteroids
6.4. Uric Acid Drugs
6.5. Other Drug Class
7. Geographical Analysis
7.1. Asia Pacific
7.1.1. China
7.1.2. Japan
7.1.3. India
7.1.4. Australia & New Zealand
7.1.5. South Korea
7.1.6. Thailand
7.1.7. Indonesia
7.1.8. Vietnam
7.1.9. Rest Of Asia Pacific
8. Company Profiles
8.1. Abbott Laboratories
8.2. Abbvie Inc
8.3. Amgen Inc
8.4. Becton, Dickinson & Company (Bd)
8.5. Bio-Rad Laboratories Inc
8.6. Bristol-Myers Squibb Company
8.7. Eli Lilly & Company
8.8. Lupin Limited
8.9. F. Hoffmann-La Roche
8.10. Johnson & Johnson
8.11. Merck & Co Inc
8.12. Novartis Ag
8.13. Perkinelmer
8.14. Pfizer Inc
8.15. Ucb

List of Tables

Table 1: Market Snapshot - Anti-Rheumatics
Table 2: Common Symptoms Of Rheumatoid Arthritis
Table 3: Risk Factors For Rheumatoid Arthritis
Table 4: Asia Pacific Anti-Rheumatics Market, By Type, Historical Years, 2016-2019 (In $ Million)
Table 5: Asia Pacific Anti-Rheumatics Market, By Type, Forecast Years, 2020-2028 (In $ Million)
Table 6: Asia Pacific Prescription-Based Drugs Market, Historical Years, 2016-2019 (In $ Million)
Table 7: Asia Pacific Prescription-Based Drugs Market, Forecast Years, 2020-2028 (In $ Million)
Table 8: Asia Pacific Over-The-Counter Drugs Market, Historical Years, 2016-2019 (In $ Million)
Table 9: Asia Pacific Over-The-Counter Drugs Market, Forecast Years, 2020-2028 (In $ Million)
Table 10: Asia Pacific Anti-Rheumatics Market, By Drug Class, Historical Years, 2016-2019 (In $ Million)
Table 11: Asia Pacific Anti-Rheumatics Market, By Drug Class, Forecast Years, 2020-2028 (In $ Million)
Table 12: Asia Pacific Disease Modifying Anti-Rheumatic Drugs Market, Historical Years, 2016-2019 (In $ Million)
Table 13: Asia Pacific Disease Modifying Anti-Rheumatic Drugs Market, Forecast Years, 2020-2028 (In $ Million)
Table 14: Asia Pacific Nonsteroidal Anti-Inflammatory Drugs Market, Historical Years, 2016-2019 (In $ Million)
Table 15: Asia Pacific Nonsteroidal Anti-Inflammatory Drugs Market, Forecast Years, 2020-2028 (In $ Million)
Table 16: Asia Pacific Corticosteroids Market, Historical Years, 2016-2019 (In $ Million)
Table 17: Asia Pacific Corticosteroids Market, Forecast Years, 2020-2028 (In $ Million)
Table 18: Asia Pacific Uric Acid Drugs Market, Historical Years, 2016-2019 (In $ Million)
Table 19: Asia Pacific Uric Acid Drugs Market, Forecast Years, 2020-2028 (In $ Million)
Table 20: Asia Pacific Other Drug Class Market, Historical Years, 2016-2019 (In $ Million)
Table 21: Asia Pacific Other Drug Class Market, Forecast Years, 2020-2028 (In $ Million)
Table 22: Asia Pacific Anti-Rheumatics Market, By Country, Historical Years, 2016-2019 (In $ Million)
Table 23: Asia Pacific Anti-Rheumatics Market, By Country, Forecast Years, 2020-2028 (In $ Million)

List of Figures

Figure 1: Porter's Five Force Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Asia Pacific Anti-Rheumatics Market, By Type, In 2019
Figure 6: Asia Pacific Anti-Rheumatics Market, By Prescription-Based Drugs, 2020-2028 (In $ Million)
Figure 7: Asia Pacific Anti-Rheumatics Market, By Over-The-Counter Drugs, 2020-2028 (In $ Million)
Figure 8: Asia Pacific Anti-Rheumatics Market, By Drug Class, In 2019
Figure 9: Asia Pacific Anti-Rheumatics Market, By Disease Modifying Anti-Rheumatic Drugs, 2020-2028 (In $ Million)
Figure 10: Asia Pacific Anti-Rheumatics Market, By Nonsteroidal Anti-Inflammatory Drugs, 2020-2028 (In $ Million)
Figure 11: Asia Pacific Anti-Rheumatics Market, By Corticosteroids, 2020-2028 (In $ Million)
Figure 12: Asia Pacific Anti-Rheumatics Market, By Uric Acid Drugs, 2020-2028 (In $ Million)
Figure 13: Asia Pacific Anti-Rheumatics Market, By Other Drug Class, 2020-2028 (In $ Million)
Figure 14: Asia Pacific Anti-Rheumatics Market, Country Outlook, 2019 & 2028 (In %)
Figure 15: China Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 16: Japan Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 17: India Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 18: Australia & New Zealand Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 19: South Korea Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 20: Thailand Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 21: Indonesia Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 22: Vietnam Anti-Rheumatics Market, 2020-2028 (In $ Million)
Figure 23: Rest Of Asia Pacific Anti-Rheumatics Market, 2020-2028 (In $ Million)
  • Global Ketogenic Diet Therapeutics Market Growth (Status and Outlook) 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 139
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Native Bacterial Antigens Market Growth (Status and Outlook) 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 116
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Insulin Glargine and Lispro Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 132
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Immunosuppressants API Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 131
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Oral Hypoglycemic Drugs Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 164
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Animal Rabies Vaccine Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 138
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Ketogenic Diet Market Growth (Status and Outlook) 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 138
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Methenamine Hippurate Tablets Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 137
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • Global Agricultural Animal Vaccine Market Growth 2020-2025
    Published: 29-May-2020        Price: US 3660 Onwards        Pages: 165
    COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along wit......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs